Search

Author/Creator Tortora, G

1. 126OOlaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. (24th November 2019)

Authors:
Oh, D-Y; Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M J; Park, J Oh; Hochhauser, D; Arnold, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E M; McGuinness, D; Cui, K Y; Schlienger, K; Locker, G Y; Kindler, H L
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1417PPreliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations. (23rd October 2018)

Authors:
Pilotto, S; Grizzi, G; Sperduti, I; Simbolo, M; Vicentini, C; Caliò, A; Caccese, M; Mafficini, A; Carbognin, L; Corbo, V; Gkountakos, A; Santo, A; Infante, M; Brunelli, M; Scarpa, A; Tortora, G; Bria, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1584PExploring resistance to nivolumab [NIV] applying an Immune Genomic Signature (IGS) in advanced pretreated NSCLC [PRINCiPe study]. (1st October 2019)

Authors:
Pilotto, S; Vita, E; Sperduti, I; Noia, V P Di; Grizzi, G; D'Argento, E; Simbolo, M; Vicentini, C; Caliò, A; Mafficini, A; Carbognin, L; Corbo, V; Gkountakos, A; Santo, A; Brunelli, M; Martini, M; Scarpa, A; Milella, M; Tortora, G; Bria, E
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC). (23rd October 2018)

Authors:
Carbognin, L; Sperduti, I; Arpino, G; Dieci, M V; Schettini, F; Griguolo, G; Brunelli, M; Guarneri, V; Nortilli, R; Fiorio, E; Pilotto, S; Orvieto, E; Manfrin, E; Conte, P; de Placido, S; Scambia, G; Tortora, G; Bria, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 202P_PRAdherence to dietary guidelines (DG) and body weight change (BWC) in early-stage breast cancer (EBC): A prospective trial in patients submitted to nutrition evidence-based educational intervention. (13th May 2019)

Authors:
Carbognin, L; Trestini, I; Sperduti, I; Fiorio, E; Tregnago, D; Pilotto, S; Scambia, G; Tortora, G; Milella, M; Bria, E
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 470PSafety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC). (23rd October 2018)

Authors:
Calvo Ferrandiz, A; Dahan, L; Hollebecque, A; Prager, G; Andre, T; Argiles Martinez, G; Bordonaro, R; Stein, A; Tortora, G; Leger, C; Amellal, N; Tabernero, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). (21st August 2018)

Authors:
Mateo, J; Chakravarty, D; Dienstmann, R; Jezdic, S; Gonzalez-Perez, A; Lopez-Bigas, N; Ng, C K Y; Bedard, P L; Tortora, G; Douillard, J -Y; Van Allen, E M; Schultz, N; Swanton, C; André, F; Pusztai, L
Journal:
Annals of oncology
Issue:
Volume 29:Number 9(2018)
Page Start:
1895
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. (28th September 2019)

Authors:
Hammel, P; Kindler, H L; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M J; Park, J O; Hochhauser, D; Arnold, D; Oh, D -Y; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E M; McGuinness, D; Cui, K Y; Joo, S; Yoo, H K; Patel, N; Golan, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 12(2019)
Page Start:
1959
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019)

Authors:
Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E; McGuinness, D; Cui, K; Schlienger, K; Locker, G; Kindler, H
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗